pharmaceutical ingredient News
-
Bright Path Laboratories Develops New Way to Produce Active Pharmaceutical Ingredients
Bright Path Laboratories, Inc. (privately held) 3-year-old startup contract manufacturer – with offices in both Charlotte and Santa Fe, N.M. – recently got a strong show of support from The U.S. Food and Drug Administration for its patented spinning-tube-in-tube (STT) continuous-flow reactor. The agency accepted the system, the only one of its kind that manufactures active ...
-
Process Design Strategy: The Advantages of Continuous Filtration for Pharmaceutical Manufacturing
The advantages of continuous manufacturing in the chemical industry have been realized for decades. In comparison to batch processing, these advantages include smaller space requirements, lower capital, better quality, higher yield, and improved health and safety concerns among many others. The regulatory environment and relatively smaller scale operations has hindered the development of these ...
-
DERMAGO Group to expand its patent portfolio by acquiring the patents for the manufacture of the pharmaceutical agent Polyphenon® E from Mitsui Norin Co,Ltd.
DERMAGO Group (“DERMAGO”), announced today that it has acquired with immediate effect all patents regarding the manufacture of the pharmaceutical ingredient Polyphenon® E, a defined extract from green tea leaves, from the Japanese patent holder Mitsui Norin. Synonyms for “Polyphenon® E” are “defined extract from green tea leaves” and ...
-
CD Formulation: Customized Preparation of Active Pharmaceutical Ingredient Excipients to Accelerate Drug Discovery Projects
In a recent statement, CD Formulation’s management announces that the company is now capable of providing customized preparation and production services for various pharmaceutical excipients with different specifications and quality requirements. Excipients usually play important and diversified roles in drugs. They interact with the active pharmaceutical ingredients (APIs) to improve the ...
-
CD Formulation Unveils Prominent Pharmaceutical Ingredients and Excipients for Enhanced Medicine Efficacy
In the quest to develop safe and effective medicines, pharmaceutical companies rely on the precise combination of active pharmaceutical ingredients (APIs) and excipients. These crucial components play a pivotal role in the formulation of pharmaceutical drugs, ensuring optimal drug delivery and patient outcomes. Recently, CD Formulation released a comprehensive guide titled "Active Pharmaceutical ...
-
Welcome Emmanuelle Bommier, Senior Director, Business Development, to Minaris Regenerative Medicine (United States)
Minaris Regenerative Medicine (United States) welcomes Emmanuelle Bommier in the role of Senior Director, Business Development, effective August 30, 2021. In her role as head of business development for North America, reporting to CEO, Dr. Kazuchika Furuishi, Emmanuelle will be accountable for creating new business opportunities and client management for Minaris in the United States, as well as ...
-
CD Formulation Enriches Its Supply of Active Pharmaceutical Ingredient Excipients
Continuing to be a trust-worthy CRO company for drug formulation and development, CD Formulation recently announces the enrichment of its active pharmaceutical ingredient excipient offerings. Now a number of API excipients are readily obtainable at CD Formulation, including Cetrorelix Acetate, Fondaparinux Sodium, Calcitriol, Vitamine D3, Tirofiban Hydrochloride, Eptifibatide, Ferric Ammonium ...
-
Alfa Chemistry Launches API Research & Development Platform for the Pharmaceutical Industry
The past decade has witnessed a surge in the demand for active pharmaceutical ingredients (APIs). Alfa Chemistry responds quickly to such a fact and launches an integrated platform with small molecule APIs/intermediates development and manufacturing capabilities from preclinical to commercial stages. Together with the previously launched 9 popular APIs that are readily-available, including ...
-
Industry comments on generic drug user proposal
Two of the trade associations named as negotiators by the U.S. Food and Drug Administration (FDA) regarding its proposal for the imposition of generic drug user fees have filed comments regarding the proposal that may frame their negotiating posture with the Agency going forward. The Society of Chemical Manufacturers and Affiliates' (SOCMA) Bulk Pharmaceutical Task Force and the European Chemical ...
By Acta Group
-
Industry Comments on Generic Drug User Proposal
Two of the trade associations named as negotiators by the U.S. Food and Drug Administration (FDA) regarding its proposal for the imposition of generic drug user fees have filed comments regarding the proposal that may frame their negotiating posture with the Agency going forward. The Society of Chemical Manufacturers and Affiliates' (SOCMA) Bulk Pharmaceutical Task Force and the European Chemical ...
-
Chemtrade announces expansion of Texas Potassium Chloride facility
Chemtrade announced today it has begun construction on an approximately Cdn$30 million project to increase the capacity of its high purity potassium chloride manufacturing facility at Midlothian, TX by more than 50% over the next 18-24 months. In addition to the expansion, which will include a new crystallizer and downstream train, Chemtrade will construct a new upgraded packaging hall and ...
By Chemtrade
-
New recommendations to reduce pharmaceuticals in water
Active Pharmaceutical Ingredients (APIs) have become ubiquitous micro-pollutants in our waters and are becoming a growing concern. As a result of a collaboration between Swedish stakeholders, recommendations have been released that aim to reduce pharmaceuticals’ impact on waterbodies. “One single stakeholder cannot alone reduce the amount of pharmaceutical residues emitted into our ...
-
Thermo Fisher Scientific Enhances Leading Pharma Services Offering by Expanding API Manufacturing Capabilities
Thermo Fisher Scientific, the world leader in serving science, announced the expansion of its API manufacturing capabilities following the completion of its previously announced acquisition of an active pharmaceutical ingredient (API) manufacturing facility from GlaxoSmithKline (GSK). Approximately 400 employees at the Cork, Ireland, site will become part of Thermo Fisher’s Pharma Services ...
-
Protheragen-ING Joins the DCAT Association
In exciting news, Protheragen-ING officially become a member of the Drug, Chemical & Associated Technologies (DCAT) Association. This move marks a significant milestone for Protheragen-ING and highlights the company's commitment to collaboration, innovation, and growth within the global pharmaceutical community. By joining forces with DCAT, Protheragen-ING, a supplier of Vitamin C Products, ...
-
Alfa Chemistry Newly Introduces Three APIs to Meet Market Demands: Tofacitinib Citrate, Tamoxifen Citrate, and Epalrestat
Alfa Chemistry, a leading pharmaceutical supplier, has recently announced the addition of three new APIs to its full-ranged product catalog, i.e., tofacitinib citrate, tamoxifen citrate, and epalrestat. These new products are introduced to meet the growing demands of the pharmaceutical market. Tofacitinib Citrate Tofacitinib Citrate is a medication used to treat rheumatoid arthritis, psoriatic ...
-
Phyton Biotech to Showcase Specialty Fermentation at CPhI Worldwide
This October and November, Phyton Biotech will attend CPhI Worldwide 2021, both virtually and in-person to exhibit its capabilities and the wide range of applications for the company’s specialty fermentation solutions. CPhI Worldwide is the largest pharmaceutical industry trade show, bringing together pharmaceutical industry suppliers and buyers from all over the world. This year, the ...
-
Why ISC Users Choose HR Lubricating Jelly for Self-Catheterization
Millions of people rely on self-catheterization to empty their bladder due to conditions such as urinary bladder retention, spinal cord injury, traumatic brain injury, multiple sclerosis, and more. If you are an uncoated straight catheter user, a high-quality sterile catheter lubricant is an important addition to your catheter regimen to ensure a comfortable experience and reduce pain, ...
-
BOC Sciences and Spaya Join Forces to Expand Chemical Offerings
BOC Sciences, a leading chemical supplier, has partnered with Spaya, an AI-powered chemical synthesis platform, to enhance the portfolio of commercially available materials by listing an unprecedented 140,000+ chemical products. BOC Sciences supplies a diverse array of research chemicals and biochemicals while Spaya's groundbreaking technology simplifies the search and procurement process for ...
By BOC Sciences
-
CD Formulation Extends Holiday Greetings for 2023 with an Exclusive Discount
CD Formulation, a leading provider of bioformulation and analytical services, is spreading holiday cheer in 2023 with an exciting offer for its valued customers. The company is extending a generous discount on its range of innovative products and services, allowing customers to make the most of their holiday budget. Being at the forefront of the biotechnology industry, CD Formulation provides ...
-
CD Formulation Exhibits Proficiency in Contact Angle Determination of Pharmaceutical Excipients
Always at the forefront of innovation, CD Formulation, a U.S.-based chemical supplier, recently announced its commitment to providing the highest quality contact angle testing services for pharmaceutical excipients worldwide. "Meeting customer needs and exceeding customer expectations are always our long-term goals. We seize every opportunity to apply the latest science and technology to the ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you